Bayesian Capital Management’s Dillards DDS Stock Holding History

Bayesian Capital Management’s Portfolio DDS Stock Details DDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,967	Closed	-$1.28M	–	861
2022 Q4	$1.28M	Buy	+3,967	New	+$1.29M	0.19%	131
2022 Q3	–	Sell	-2,408	Closed	-$531K	–	762
2022 Q2	$531K	Sell	2,408 -311	-11%	-$89.8K	0.1%	320
2022 Q1	$730K	Buy	+2,719	New	+$702K	0.11%	275
2021 Q2	–	Sell	-2,623	Closed	-$253K	–	458
2021 Q1	$253K	Buy	+2,623	New	+$213K	0.06%	393
2020 Q2	–	Sell	-8,561	Closed	-$316K	–	579
2020 Q1	$316K	Buy	8,561 +4,161	+95%	+$243K	0.07%	434
2019 Q4	$323K	Buy	+4,400	New	+$312K	0.06%	410
2019 Q3	–	Sell	-4,123	Closed	-$257K	–	551
2019 Q2	$257K	Buy	+4,123	New	+$265K	0.05%	391
2018 Q3	–	Sell	-8,500	Closed	-$803K	–	660
2018 Q2	$803K	Sell	8,500 -2,800	-25%	-$228K	0.18%	153
2018 Q1	$908K	Buy	+11,300	New	+$816K	0.23%	143

Other funds holding DDS

Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CWM

ClientFirst Wealth Management Little Rock, Arkansas $118M AUM 40.43% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Bayesian Capital Management's DDS Position: Q1 2023 in Review

Bayesian Capital Management sold out of Dillards (DDS) in Q1 2023, closing a stake of 3,967 shares — an estimated $1.28M sold.

Bayesian Capital Management first reported a position in DDS in Q1 2018 and held it in 9 quarters. The position peaked at $1.28M in Q4 2022. 231 funds tracked by Wall St. Rank hold DDS as of Q1 2023.

Bayesian Capital Management reported no remaining Dillards position as of Q1 2023 after selling out during the quarter.
Bayesian Capital Management sold 3,967 Dillards shares in Q1 2023, an estimated $1.28M.
Bayesian Capital Management first reported a position in Dillards in Q1 2018 and held it in 9 quarters.
Bayesian Capital Management's Dillards position peaked at $1.28M in Q4 2022.
231 funds tracked by Wall St. Rank held Dillards as of Q1 2023.

Based on Bayesian Capital Management's 13F filing for Q1 2023, filed 15 May 2023.